First Word Pharma carries word of a health warning issued to cancer patients and their healthcare professionals regarding Aranesp; as the drug now carries the risk of Stevens-Johnson syndrome, as well as other severe side effects.
Stevens-Johnson syndrome is a potentially life-threatening condition, and use of Aranesp should be discontinued immediately if SJS symptoms develop. Patients may at first exhibit flu-like symptoms such as fever, exhaustion, and ...
continue reading...